Janus Henderson Group
ABUS icon

Janus Henderson Group’s Arbutus Biopharma ABUS Stock Holding History

Janus Henderson Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Hold
60,900
– – ﹤0.01% 2248
2025
Q4 		$293K Hold
60,900
– – ﹤0.01% 2217
2025
Q3 		$277K Hold
60,900
– – ﹤0.01% 2245
2025
Q2 		$188K Hold
60,900
– – ﹤0.01% 2333
2025
Q1 		$213K Hold
60,900
– – ﹤0.01% 2337
2024
Q4 		$199K Hold
60,900
– – ﹤0.01% 2429
2024
Q3 		$234K Buy
+60,900
New +$234K ﹤0.01% 2372

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Janus Henderson Group's ABUS Position: Q1 2026 in Review

Janus Henderson Group held its Arbutus Biopharma (ABUS) position steady in Q1 2026 at 60,900 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Janus Henderson Group first reported a position in ABUS in Q3 2024 and has held it in 7 quarters since. The position peaked at $293K in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Janus Henderson Group held 60,900 shares of Arbutus Biopharma worth $274K as of Q1 2026.
  • Janus Henderson Group left its Arbutus Biopharma share count unchanged in Q1 2026.
  • Arbutus Biopharma made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2248 holding.
  • Janus Henderson Group first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 7 quarters since.
  • Janus Henderson Group's Arbutus Biopharma position peaked at $293K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.